Acute myeloblastic leukemia (AML) blasts have been shown t o produce a variety of cytokines in culture such as interleukin-1 (IL-1 1, and granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-a (TNFa). Using two sensitive and specific enzyme-linked immunosorbent assays for IL-18 and GM-CSF, we document in the present study that the production of the t w o cytokines by AML blasts in culture is coordinated. First, we observe a striking correlation between the levels of GM-CSF and IL-18 released by the cells. Thus, a high production of IL-18 is always concordant with a high production of GM-CSF and, conversely, low production of IL-18 is concordant with low levels of GM-CSF. Second, neutralization of intrinsic IL-1 using antibodies that are specific for IL-la and -18 suppresses the release of GM-CSF by the cells. Third, neutralization of the endogenous source of IL-1 also results in an EVERAL CELL TYPES, such as monocytes, fibro-S blasts, and transformed cell lines (reviewed in refs. 1 and 2), are capable of producing more than one growth factor. The blast cells of acute myeloblastic leukemia (AML) also appear to produce several growth but the mechanism of a possible coordinate growth factor production is yet to be documented.
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AML blasts have been shown to proliferate in culture in the presence of exogenous growth factors such as granulocytemacrophage (GM-CSF) and granulocyte colony-stimulating factor (G-CSF)9"' and interleukin-3 (IL-3).I2 With the availability of recombinant proteins, it has become evident that the effect of any single growth factor is suboptimal and that blast colony formation in culture requires the synergistic effect of a combination of factors such as GM-CSF with G-CSFI3-" or IL-1,I6 IL-6,I7 and tumor necrosis factor-a (TNFa)." We and others have shown that part of the proliferative effect of IL-1 on AML blasts is due to induction of GM-CSF production by the cell^.'^*'^ Synergistic growth stimulation by several growth factors has also been docugesting that such multifactorial effect is not limited to AML blasts.
The dependency of AML blasts on exogenous growth factors for colony formation has led to the assumption that autocrine growth factor production might not be a common event in AML (reviewed in ref. 23 ). This was disputed in more recent work which indicated that autostimulation occurs under conditions that favor cell to cell i n t e r a~t i o n~~ and that some AML samples express GM-CSF mRNA or G-CSF, IL-I@, IL-6, and TNFa ~R N A s .~. ' ,~~ Since IL-1 and TNF can induce CSF production by endothelial ~e l l s ,~~-~' it has been suggested that cytokine production by AML blasts allows recruitment of accessory cells in a paracrine loop that supports leukemic cell pr~liferation.~.~
In view of the fact that IL-1 can induce GM-CSF production by AML blasts and that IL-1 acts synergistically with GM-CSF in stimulating blast colony formation, the mented for normal hemopoietic progenitor cells,'6-'7.20-22 sugabrogation of GM-CSF mRNA. Fourth, the production of both IL-18 and GM-CSF is up-regulated by exposing AML blasts t o an exogenous source of IL-1, suggesting a positive regulation of autocrine growth factor production. Taken together, our results indicate that GM-CSF production by AML blasts is mediated by endogenously produced IL-1 .
Both IL-la and -l a are produced by AML blasts, although IL-18 appears t o be more abundant. Spontaneous colony formation by AML blasts is abrogated by the addition of neutralizing antibodies against IL-18 and GM-CSF, whereas each antibody alone has little effect on blast proliferation. Taken together, our results are consistent with the view that the production of IL-18 by AML blasts supports autocrine growth in culture, through induction of CSFs or other cytokines that stimulate blast proliferation. 0 1990 by The American Society of Hematology.
production of IL-1 by AML blasts may well represent an important element of their autocrine growth.
The aim of the present study is to determine whether coordinate production of IL-1B and GM-CSF might be a common event in AML, to investigate the mechanism of a coordinate production, and, finally, to study the regulation of growth factor production by the cells. We have therefore developed two sensitive and specific enzyme-linked immunosorbent assays (ELISAs) for IL-1B and GM-CSF, with detection limits in the order of picograms. We have thus shown that a majority of AML samples surveyed in our study are capable of releasing both IL-lB and GM-CSF in culture, and that the production of the two cytokines is coordinated. Our data indicate that GM-CSF release is mediated by endogenously produced IL-1, suggesting that the primary event underlying coordinate growth factor production by AML blasts is the activation of IL-1 gene expression. Using neutralizing antibodies against IL-1 and GM-CSF, we further show that the coordinate production of the two growth factors is an essential component of AML blast autostimulation in culture. Finally, GM-CSF and IL-lp 1482 RODRIGUEZ-CIMADEVILLA ET AL production is increased on exposure of the cells to IL-la, suggesting a positive regulation of autocrine growth factor production.
MATERIALS AND METHODS

Source of Cells and Growth Factor
AML blasts were separated from the peripheral blood of patients with diagnosed AML by Ficoll-Hypaque centrifugation. Cells were stored frozen in liquid nitrogen until use. A programmed freezing rate of 1°C per minute ensured a viability higher than 98% on thawing3' Clinical data and cell morphology, determined at the same time as growth factor production, are shown in Table 1 .
Human IL-la and -j3 were produced by bacterial transformation and purified to a specific activity of 10' U/mg.32333 Purified recombinant GM-CSF was a generous gift from Dr S.C. Clark (Genetics Institute, Cambridge, MA). Serum-free conditioned medium from the bladder carcinoma cell line 5637 (A.T.C.C.) was harvested 1 week after confluency as described previously (5637 CM).34
Source of Antibodies
The neutralizing antibodies against human IL-la and -1s were produced in sheep. A dilution of 1:50,000 was sufficient to neutralize 100 pg/mL of the corresponding growth factor. They were specific for IL-1 and did not affect IL-3, IL-6, G-CSF, and GM-CSF supported colony formation." The neutralizing antibody against GM-CSF was produced in sheep and was a generous gift from Dr S.C. Clark. A dilution of 1500 was sufficient to neutralize 600 pg/mL of GM-CSF. The antibody did not affect IL-3 supported colony formation.I6
The monoclonal antibody against human IL-lj3 (ILBl-H34) was a generous gift from Dr J.S. Kenney (Syntex Research, Palo Alto, CA).35 The monoclonal antibody against human GM-CSF was obtained from Genzyme (Boston, MA) and used as described below. Both monoclonal antibodies were purified by protein A Sepharose chromatography.
Culture Conditions
AML blasts were plated in methylcellulose cultures at the indicated cell concentrations in 100 pL of IMDM (Gibco, Grand Island, NY), viscified with 1% methylcellulose (Fluka, Switzerland) and supplemented with 10% fetal calf serum (FCS, Gibco) to determine spontaneous colony formation. Positive controls containing 10% 5637 CM were included in each e~periment.'~ Colonies containing more than 20 cells were scored on days 4 to 6 of culture, as indicated.
Immediately after thawing, AML blasts (lo6) were incubated in 1 mL of IMDM supplemented with 10% FCS in 35-mm suspension culture dishes (Lux, Naperville, IL). Supernatants were harvested at 24 hours, unless otherwise stated, and stored at 4OC until use. Where indicated, enzyme inhibitors were added at the following concentrations: aprotinin, 0.02% (Sigma, St Louis, MO) and PMSF, mol/L (Sigma). The supernatants stored at 4OC in the absence of enzyme inhibitors were stable for at least 4 weeks and gave the same results after storage. Serum-free cultures were supplemented with 2% bovine serum albumin (BSA, Sigma) and 300 pg/mL purified human transferrin (Sigma), twothirds saturated with iron as described previo~sly.~~
IL-lP and GM-CSF ELISA
The test was a double sandwich peroxidase ELISA adapted from a procedure described by Kenney et and all the steps were essentially the same for the two proteins.
Briefly, microwells (Removawell, Dynatech Laboratories Inc, Chantilly, VA) were coated with a monoclonal antibody to either IL-10 (ILBl-H34, 1 pglwell) or GM-CSF (Genzyme, 1 pglwell) in 100 pL of 5 mmol/L glycine buffer (pH 9.2) and incubated overnight at room temperature. The wells were then washed with phosphate buffered saline (PBS) containing 0.1% Triton X-100 (Sigma) and saturated with 200 pL of PBS supplemented with 1% BSA for 45 minutes. The antibody-coated wells were then incubated for 1 hour with serial dilutions of standard and samples, all in duplicate. Excess growth factors were removed by extensive washing, and the polyclonal rabbit anti-IL-1 (Cistron Biotechnology,
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Pine Brooks, NJ; 1:lOO in PBS/I% BSA) or anti-GM-CSF (Genzyme; 1:1,000 in PBS/I% BSA) was added to the wells for I hour, washed, followed by a 30-minute incubation with a peroxidasecoupled goat anti-rabbit antiserum (Cistron Biotechnology; 1 : 100 in PBS/l% BSA). The volume of reagents was always I00 pL, and excess reagent was always removed by three washes with PBS/O. 1 % Triton, unless otherwise specified. Finally, the substrate was added (orthophenylenediamine [Sigma], 1 mg/mL in aqueous solution containing 0.0021% vol/vol of hydrogen peroxide) and the reaction allowed to proceed at 37OC for 35 minutes. The enzymatic reaction was stopped by the addition of 50 pL of 2 mol/L sulfuric acid and the optical density read in a microplate autoreader (EL310, Bio-Tek Instruments, Burlington, VT) at 490 nm (ODd9,,). The standard curves were analyzed by linear regression for concentration windows of 0 to 100 pg/mL and 100 to 1,000 pg/mL (r = .99). Results were extrapolated from the standard curves. Both tests were specific and did not detect the other cytokines or growth factors, such as TNFa, G-CSF, IL-6, or IL-la, up to 4 ng/mL.
Northern Blot
RNA from AML blasts was extracted in the presence of guanidium, and purified by acid phenol e~traction.~' The RNA was denatured in the presence of glyoxal, size fractionated by electrophoresis;8 and transferred to a Nytran membrane (Schleicher and Schuell, Keene, NH). Prehybridization and hybridization were done in the presence of heparin as described previously.I6 Specific IL-16 and GM-CSF transcripts were detected by hybridization with full-length cDNAs that were labeled by random priming."
The human GM-CSF4O and IL-lp4' cDNA were kindly provided by Drs G.G. Wong and S.C. Clark (Genetics Institute, Cambridge, MA). RNA loading was verified through hybridization with @-actin cDNA and, in parallel, through ethidium bromide staining of separate gels. Briefly, 1 pg of RNA from each sample was electrophoresed in the presence of 25 mmol/L methyl mercuric hydroxide in sodium borate and sulfate buffer. The gel was stained with 0.5 pg/mL ethidium bromide in 0.1 mol/L ammonium acetate?'
RESULTS
GM-CSF ELISA
To quantitate GM-CSF and IL-lB production by AML blasts, we devised two sensitive ELISA for the two cytokines.
Serial dilutions of the monoclonal antikGM-CSF were fixed to the wells to determine the optimal concentration for the detection of GM-CSF. A concentration of 1 pg/well of antibody was found to be sufficient; higher antibody concentrations did not result in a higher fixation of GM-CSF to the well (data not shown). However, when the peroxidase enzymatic reaction was performed at 37OC, the sensitivity of the assay was much improved compared with room temperature incubations, which were recommended in other protocols." Thus, concentrations of GM-CSF of 15 pg/mL (or 1.5 pg/well) gave an absorbance a t 490 nm which was significantly and reproducibly higher than the negative controls (PBS/ 1 % BSA and IMDM/ 10% FCS), as shown in Fig 1. To devise an IL-IP-specific ELISA, monoclonal antibodies against IL-lP were obtained from different sources. Of the ones tested, only the ILBl-H34 gave a sensitivity comparable to the GM-CSF ELISA described above. The resolution of the IL-la ELISA in our hand was comparable to that described initially by Kenney et a135 using the same antibody. 
GM-CSF and IL-l/3 Production by AML Blasts
Using the two sensitive and specific ELISAs, we were able to detect GM-CSF and IL-lP production in all AML samples studied except AML 9 (Fig 2) . There was a striking correlation between the levels of GM-CSF production and those of IL-la production ( r = 37). The production of the two growth factors exceeded 1 ng/ lo6 cells in seven samples and was lower than 300 pg in the others.
To verify whether growth factor production in culture might be induced by serum components, levels of GM-CSF and IL-16 were compared in culture supernatants of AML blasts done in the presence or absence of serum (Fig 3) . For Production of the two cytokines was comparable in serumfree medium or in the presence of 10% FCS, indicating that FCS was not an inducing factor for GM-CSF and IL-I production by AML blasts.
Role of IL-I as an Endogenous Inducer of GM-CSF Production
IL-l has been shown to induce the production of GM-CSF by AML blasts." We therefore asked whether the endogenous production of GM-CSF was mediated by endogenously produced IL-I. Neutralizing antibodies against IL-la and lL-l@ were therefore added to cultures of AML blasts (Fig  4) . We have previously observed the presence of IL-I@-specific transcripts in Northern blots from AML blasts," whereas IL-la transcripts were not detectable (Hoang, unpublished observation). In the following experiments, we have added, however, antibodies against both IL-la and -I @ in order to ensure a complete neutralization of the endogenous source of IL-I. In all four samples selected for high GM-CSF production (1 ng/mL to 30 ng/mL), antibodies against IL-la and IL-IP drastically reduced the levels of GM-CSF produced by the cells. This large disparity in GM-CSF production was not due to differences in cell numbers, since the antibodies did not affect cell count in the 24-hour incubation period, nor was it due to interference of high concentrations of anti-IL-la and -I @ in the GM-CSF detection assay, because the antibodies did not affect the assay when added simultaneously to known concentrations of GM-CSF standards (data not shown).
As control, antibodies against GM-CSF were added to the same cells. The antibody did not suppress IL-I@ production (Fig 4) , suggesting that IL-l@ production was independent of GM-CSF production. Consequently, our data indicate that GM-CSF production in AML blasts may be secondary to that of IL-I.
The expression of IL-I@ and GM-CSF mRNA by AML blasts in the presence or absence of anti-lL-l was determined by Northern blot analysis (Fig 5 ) . In control cells, both IL-I@ mRNA and GM-CSF mRNA were detectable. Addition of anti-lL-la and anti-IL-I@ antibodies caused a dramatic decrease in GM-CSF gene expression in the cells, in good agreement with data observed at the protein level. The intensity of ethidium bromide staining of size-fractionated RNA samples from control cells and antibody-treated cells were comparable, indicating similar RNA loading. Quantitation by scanning densitometry, after correction for the difference in RNA loading on the basis of @-actin mRNA, indicated a threefold decrease in GM-CSF transcripts, on exposure of the cells to antibodies against IL-la and 1L-1@. Taken together, our data indicate that endogenous IL-I production up-regulates or activates the production of GM-CSF by AML blasts a t the transcriptional level.
Role of IL-lp and GM-CSF in Autocrine Stimulation of AML Blast Colony Formation
In a first series of experiments, we have sought to neutralize the effects of GM-CSF and IL-1@ only, because of the lack of IL-la transcripts observed previously." AML blasts were plated at threeconcentrations: IO4. 2 x IO4, and 3 x IO4 per well. Spontaneous colony formation usually occurred at the two higher cell concentrations except for AML 9, whereby no spontaneous colony formation was observed, even at 3 x IO4 cells/well ( Table 2) . This sample was, however, capable of colony formation in the presence of exogenous growth factors. On addition of a polyclonal 
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Given the fact that anti-IL-la and -1s could suppress GM-CSF production (Fig 4) . we next question whether higher concentrations of anti-IL-16 or a combination of IL-la and IL-16 would be sufficient to block autonomous colony formation by AML blasts in the absence of anti-GM-CSF. Three concentrations of either anti-IL-l@ or anti-I L -l a were added to cultures of AML blasts and compared with the combined effects of the two antibodies (Table 3) . Anti-IL-la alone had little effect on blast colony formation. whereas a significant dccrease in colony formation was observed after the addition of anti-IL-IS alone in AML 25 ( R ) and AML 26 cells. 90 further dccrease in colony count was observed at higher concentrations of anti-IL-13 (data not shown). In contrast. blast colony formation was completely inhibited after the addition of both anti-IL-la and anti-IL-lB in two of three samples. Similarly. anti-IL-16 and anti-GM-CSF clearly had a complete suppressive effcct on blast colony formation ( Table 2 ). suggecting that the residual level of GM-CSF produced in the presence of anti-IL-I@ alone might bc mediated by endogenously proTaken together, our data indicated that ( I ) IL-I production by AML blasts is the primary event underlying the coordinate release of both IL-I and GM-CSF. through induction of GM-CSF release by endogenous IL-I: (2) both duced IL-la. AML blasts were plated at three cdl concennatms as descriibsd in Mataids end Melhods, in the absence of exogan~m gowth fectms. mth a wchout anttboches against humen GM-CSF m d / a humm IL-1 A. Data. shown f a 2 x 10' cellr/well. represent the arerege of five rePlicace cuhues t SD. The sheep anti-GMCSF was used at a chlutm of 1:300 end the sheep enti-11-18 was used at a dilution of 1:600. F a each AML sampb. a positive control wlth 5637 CM (10%) w w included. F a AML 9. colony count in the &twa connd was 252.
For AML blasts were cultured at 2 x 104/well in the presence of the different antibodies at final concentrations of 1 :300, 1: 100, and 1:50 (data shown *No growth factor was added. tControl for antibody specificity was determined in culture of AML 25 (R) cells stimulated with IL-3. The cells were plated at 7.000 cells/well, under for 1:300).
which condition colony formation was entirely dependent on IL-3 addition.
IL-la and IL-l/3 were produced by AML blasts, but JL-10 appeared to be the most abundant; and (3) complete neutralization of the endogenous source of IL-1 was sufficient to suppress colony formation, probably due to suppression of autocrine CSF production.
Eflect of IL-la on IL-lB and GM-CSF Production by AML Blasts
To determine whether cells that were not capable of growth factor production spontaneously would be able to do so on stimulation, AML blasts were incubated in the presence of optimal concentrations of rIL-la. Supernatants were harvested after 24 hours and tested for the presence of IL-lB and GM-CSF. The production of both GM-CSF and IL-lp by the cells was enhanced by the addition of increasing concentrations of IL-la, with an optimum between 2 to 6 ng/mL (data not shown). Concentrations of IL-la of 4 ng/mL were used thereafter to assess induction of growth factor production by AML blasts (Table 4) . Thus, five of six AML samples responded to the effects of IL-la by a significant increase in growth factor production, whereas sample AML 9 failed to produce any detectable growth factor, even on exposure to IL-la.
DISCUSSION
A large majority of AML samples surveyed in the present study showed a constitutive production of both IL-10 and GM-CSF. Several lines of evidence indicate that the production of the two cytokines is coordinated, due to activation of GM-CSF gene expression by endogenously produced IL-10.
We initially observed a good correlation between the levels of IL-1 and GM-CSF produced by AML blasts, raising the possibility that GM-CSF production may be induced by endogenously produced IL-1. A direct confirmation of the role of IL-1 came from the demonstration that neutralization of the endogenous source of IL-1 using specific antibodies against IL-la and -18 abrogated GM-CSF production by AML blasts in all four samples tested. Finally, we also show that anti-IL-1 treatment resulted in a drastic decrease in GM-CSF mRNA expression in AML blasts, suggesting a direct implication of endogenous IL-1 in activation (or up-regulation) of the transcription of GM-CSF gene. IL-1 is known to induce GM-CSF production in a variety of cells such as monocytes, fibroblasts, endothelial cells, and AML blasts. 16.19.28. 29 Our data suggest that endogenously produced IL-1 has the same property. However, the antibodies against IL-Is did not completely suppress either GM-CSF production or GM-CSF gene expression in AML blasts. It is possible that cytoplasmic IL-I' is not affected by the antibodies, assuming that IL-1 may be active intracellularly, as has been documented for IL-3.43 IL-1 and TNFa mRNA levels are upregulated by exposing the cells to the corresponding pr~tein?~,~' suggesting a positive feedback regulation. There is, however, no direct evidence of protein production, due to the difficulty in distinguishing exogenously added and endogenously produced growth factor. It was possible here to quantitate protein production because IL-la was used as exogenous growth factor, allowing the monitoring of IL-Ip production. These two molecules are products of separate genes and Cells were thawed and incubated at 1 x lo6 in IMDM supplemented with 10% FCS, with or without IL-la at a concentration of 4 ng/mL.
Supernatants were harvested and measured by ELSA as described in Fig 2. For personal use only. on November 15, 2017. by guest www.bloodjournal.org From share only 30% sequence homology, yet bind to a common membrane r e~e p t o r~' .~~ and elicit the same in vivo and in vitro responses!' Using a highly specific monoclonal antibody against IL-lB, we could detect picogram amounts of IL-la in the absence of any cross-reactivity with IL-la. It is thus shown unequivocally that IL-1 can up-regulate its own production by AML blasts, which may be the basis for self-sustaining autocrine stimulation. In monocytes, IL-10 is more continuously released from the cells and in greater amount than IL-la."8 We have shown previously that AML blasts express IL-la mRNA," but we were not able to detect IL-la mRNA. It is shown in the present study that both IL-la and -18 are produced by AML blasts, although IL-1/3 appears to be the most abundant.
Because monocytes had been shown to produce IL-1, it was important to address the question of whether the production detected in our culture system was due to monocyte contamination. Morphologic determination indicated that most of our AML samples contained more than 93% blasts. Among the samples that we could use to quantitate growth factor production, only two had monocyte contamination of 1% (AML 19) and 3% (AML 26), and four had lymphocyte contamination of 4% to 5% (AML 19, AML 20, and AML 26) and 14% (AML 3). However, both IL-lB and GM-CSF levels released by these AML cells ranged from 900 to 2,600 pg/mL. Therefore, it seems unlikely that the few remaining accessory cells could account for such a high production.
IL-18 transcripts in AML blasts appeared as a single band of 1.8 Kb, consistent with published result^,'^^^' whereas GM-CSF transcripts seemed to migrate as two bands of approximately 1 Kb, consistent with data reported by Kaushansky in normal human endothelial cells49 and by Thorens et a1 in normal murine ma~rophage.~' The possibility of two distinct GM-CSF transcripts should be further investigated using primer extension analysis. IL-la and GM-CSF transcripts were detectable in cultured cells only, in agreement with data reported by van der Schoot et a1 for IL-1/3 and IL-6 mRNA expression by AML blasts." No IL-la-specific transcript was detectable before culture at 37OC (data not shown and ref 51). Although the production of IL-18 may be induced in culture, our results indicate that serum growth factors are not required for such production.
Elevated IL-lP plasma levels in AML patients would also be indicative of an involvement of IL-ls in the biology of the disease. However, van der Schoot et a1 have indicated that they have not been able to detect IL-1 or IL-6 in sera from AML patients or healthy control^.^' Using our ELISA, we estimate IL-la plasma levels in healthy donors to be in the range of 40 to 80 pg/mL (unpublished observations). We have been able to determine IL-la plasma levels in only a few AML patients, due to the fact that the study was done in retrospect on our bank of frozen cells. No significant elevation in IL-la plasma levels is observed in the AML samples tested (data not shown). These observations do not rule out the possibility that IL-10 may be transiently induced at some time during the course of the disease.
AML blasts have been shown to express several growth factor genes: IL-la, GM-CSF, G-CSF, IL-6, and TNFcu. More recently, van der Schoot et a1 have also shown a remarkable correlation between the levels of IL-1 and IL-6 produced by AML blasts:' similar to the one documented here for IL-1 and GM-CSF production. Furthermore, we present evidence that antibodies against IL-la and IL-l& cause a significant decrease in GM-CSF transcripts, and in GM-CSF protein production, suggesting that the production of GM-CSF is mediated by endogenously produced IL-18. In other systems, IL-1 and TNF have been shown to induce the expression both G-and GM-CSF mRNA26-30 and IL-6 ~IRNA.'**~~ If the parallel is to be drawn between exogenous and endogenous IL-1, it may be inferred from our study that the coordinated expression of G-CSF, GM-CSF, and IL-6 genes by AML blasts in culture may be mediated by endogenously produced IL-1. 
